Seattle Genetics

Seattle Children's teams up with Juno competitor on gene editing research
Bizjournals.com
Fri, 09/11/15 - 05:49 pm
Seattle Genetics
Juno Therapeutics
Bluebird Bio
gene editing
Seattle Genetics sets out to raise $400M through common stock offering
Bizjournals.com
Wed, 09/9/15 - 09:59 pm
Seattle Genetics
stock offering
Seattle Genetics drug wins FDA approval, could boost biotech's revenue
Bizjournals.com
Tue, 08/18/15 - 09:23 pm
FDA
Seattle Genetics
Adcetris
Hodgkin's lymphoma
Seattle Genetics reports 2nd-quarter loss, misses expectations
Yahoo/AP
Fri, 07/31/15 - 11:00 am
Seattle Genetics
earnings
Growing Seattle Genetics tests cancer therapy for treatment of lupus
Bizjournals.com
Thu, 07/9/15 - 07:49 pm
Seattle Genetics
lupus
Adcetris
Seattle Genetics conjugates with immuno-oncology upstart Unum in $645M deal
Fierce Biotech
Mon, 06/8/15 - 10:53 am
Seattle Genetics
immuno-oncology
Unum Therapeutics
Top-Performing Biotech and Drug Stocks During ASCO '15
TheStreet.com
Fri, 06/5/15 - 07:13 pm
ASCO
Ignyta
Immunogen
Puma Biotechnology
AbbVie
Roche
Bristol-Myers Squibb
Seattle Genetics
Juno Therapeutics
Workers wanted: Seattle Genetics experiencing a growth spurt
BioPharma Dive
Mon, 04/27/15 - 10:59 am
Seattle Genetics
hirings
Seattle Genetics on a 'great trajectory,' looks to grow staff by 100
Bizjournals.com
Sat, 04/25/15 - 08:36 am
Seattle Genetics
hirings
4 Big Biopharma Deals We Might See In 2015
Seeking Alpha
Fri, 04/17/15 - 08:42 am
AbbVie
AstraZeneca
Biomarin
Bristol-Myers Squibb
Celgene
Gilead Sciences
GSK
Hospira
Jazz Pharmaceuticals
Merck
Seattle Genetics
Shire
4 big biopharma deals we might see in 2015
BioPharma Dive
Mon, 04/6/15 - 10:51 am
M&A
Merck
Jazz Pharmaceuticals
Shire
Biomarin
Gilead Sciences
Seattle Genetics
Pfizer
Celgene
Seattle Genetics reports fourth-quarter loss but tops expectations
Yahoo/AP
Wed, 02/11/15 - 08:59 am
Seattle Genetics
earnings
Seattle Genetics: Good Tech, But On The Wrong Path
Seeking Alpha
Fri, 12/19/14 - 08:46 am
Seattle Genetics
antibody-drug conjugate
The 7 Most Important Drug-Stock Lessons From This Weekend's Blood Cancer Meeting
TheStreet.com
Mon, 12/8/14 - 10:30 am
Agios Pharmaceuticals
Novartis
CAR-T
Celgene
Amgen
Merck
Bristol-Myers Squibb
Seattle Genetics
Sunesis
Seattle Genetics Makes Case for Expanded Use of Adcetris as Lymphoma Maintenance Therapy
The Street
Sun, 12/7/14 - 10:09 am
Seattle Genetics
Adcetris
Hodgkin's lymphoma
Seattle Genetics Presents Data from SGN-CD19A Antibody-Drug Conjugate at ASH Annual Meeting
Yahoo/BusinessWire
Sun, 12/7/14 - 09:28 am
Seattle Genetics
SGN-CD19A
acute lymphoblastic leukemia
leukemia
non-Hodgkin's lymphoma
diffuse large B-cell lymphoma
Seattle Genetics and Takeda Report Phase 3 AETHERA Clinical Trial Data from ADCETRIS® (Brentuximab Vedotin) in Post-Transplant Hodgkin Lymphoma Patients at Risk of Relapse at ASH Annual Meeting
Yahoo/BusinessWire
Sat, 12/6/14 - 11:15 am
Seattle Genetics
Takeda
Adcetris
Hodgkin's lymphoma
Today's Water-Logged And Getting Wetter Stock: Seattle Genetics (SGEN)
TheStreet.com
Tue, 11/25/14 - 01:33 pm
Seattle Genetics
Aegerion, Seattle Genetics CEOs Accused in Suit of Cocaine Use
TheStreet.com
Mon, 10/27/14 - 10:50 am
Aegerion
Seattle Genetics
Pharma CEOs
Seattle Genetics Seeks Expanded Use of Lymphoma Drug Following Study Win
TheStreet.com
Mon, 09/29/14 - 10:16 am
Seattle Genetics
Adcetris
Hodgkin's lymphoma

Pages